Empagliflozin is a potential treatment for outpatients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis (SIAD), new data suggest. The sodium-glucose cotransporter 2 (SGLT2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback